Latest HairMax LaserComb Stories
Lexington Int’l announces the creation of the ‘SWITCH’ Program, which offers a discount for purchase of the HairMax LaserComb® for men with hereditary hair loss who wish to switch treatment
An analysis undertaken to assess the safety and efficacy of the HairMax LaserComb from 6 double blind clinical studies with 460 subjects found that no serious side effects occurred in any of
Lexington Int'l announces that FDA Marketing Clearance has been granted for the HairMax Advanced 7 and Professional 12 models, for the treatment of androgenetic alopecia (hereditary hair loss)
SILVER SPRING, Md., Aug. 15, 2011 /PRNewswire-USNewswire/ -- For the first time, the U.S.
SILVER SPRING, Md., July 26, 2011 /PRNewswire-USNewswire/ -- The U.S.
An examination of publicly available FDA data by Emergo Group on 510(k) clearances over the last five years indicates that 80% of devices receive clearance within six months. Austin, TX (PRWEB) June 22, 2011 Emergo Group, an Austin-based consulting firm that assists medical device manufacturers with regulatory compliance, has completed a comprehensive analysis of medical device 510(k) submissions cleared by the US Food and Drug Administration (FDA).
BOCA RATON, Fla., April 21, 2011 /PRNewswire/ -- Lexington International, LLC is pleased to announce that it has successfully completed 2 clinical studies of the HairMax LaserComb proving the efficacy and safety of 3 new devices for the treatment of androgenetic alopecia (hereditary hair loss).
Most medical devices recently recalled by the Food and Drug Administration because of very serious risks were initially approved through an expedited process or were exempt from regulatory review, according to a report posted online today that will be published in the June 14 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals. "Unlike prescription drugs, medical devices are reviewed by the U.S. Food and Drug Administration (FDA) using two alternative regulatory...
The US Food and Drug Administration (FDA) announced Wednesday it plans to update its 35-year-old system that is used to approve most medical devices, which has come under increased criticism from public safety advocates.
Company cited for significant manufacturing violations SILVER SPRING, Md., Jan. 13, 2011 /PRNewswire-USNewswire/ -- U.S. Marshals, acting under a court order sought by the U.S. Food and Drug Administration, on Jan.
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.